On August 8th, Haiyin (000861.SZ) announced that he received the “Investigation Notice” (number: Yue Certificate Investigation Tongzi No. 190135) on July 26, 2019, due to the company Suspected information disclosure of illegal and violations, in accordance with the relevant provisions of the Securities Law of the People’s Republic of China, the China Securities Regulatory Commission decided to investigate the company.
On August 8, 2019, the company and related parties received the “Administrative Penalty Prior to Administrative Penalty Promotion” issued by the Guangdong Regulatory Bureau [Guangdong Securities Regulatory Punishment  No. 11]. The following penalties are planned:
1. A warning of Haiyin shares and imposed a fine of 350,000 yuan;
2. A warning to Shao Jianming and imposed a fine of 100,000 yuan; [[[[[[[[[[[[ 123]
3. Warning to Shao Jianjia and Pan Wei, and fined 50,000 yuan.
The Securities and Futures Commission pointed out that after being found out, Haiyin’s suspected illegal facts are as follows:
In order to cooperate, the industrialization operation of today’s pearl polysaccharides in African swine fever, Haihai India shares signed the “Cooperation Contract” on June 11, 2019 with Xu Mantai and Hainan Jinzhu Agricultural Development Co., Ltd. (hereinafter referred to as Jinzhu Company), and released the “Signing u0026 LT; Cooperation Contract u0026 GT; Announcement “(Announcement number: 2019-54, hereinafter referred to as announcement No. 54), disclosed the contract signing situation, the introduction of the contract, the main content , Misleading statement or major omissions. Specific:
First, the status of the contractual patent technology application disclosed disclosed by the 54th announcement is inconsistent with the actual situation. On May 24, 2019, Xu Mantai and Xu submitted patent applications to the State Intellectual Property Office and received acceptance. “”. As of the announcement of the announcement of the 54th, the above -mentioned patent application was still in a state of automatic acceptance. At that time, it was not authorized. It was uncertain whether it could be approved in the end. In the announcement of Haiyin’s announcement on the 54th announcement, “Professor Xu Moutai and his research team made certain research results on the prevention of African swine fever, and had relevant patented technologies.” Polysaccharide injection ‘and information such as patent rights (including patent application) “and other information, which are inconsistent with the actual situation.
Second, the contracting shareholders and actual controllers disclosed by Announcement 54 are inconsistent with the actual controller. On May 24, 2019, Jinzhu Company was registered and established. Xu and Chen Mouyu each held 50%of the equity, and Xu was the legal representative. Among them, Xu Mou and Chen Mouzhang are both holders. All the equity of the contract C and Jinzhu is actually held by Party B Xu Mantai and his R u0026 D team. Haiyin shares in 54The announcement of the announcement “Shareholder Xu is the actual controller of the company, holds 50%of the company’s equity, and shareholders Chen Mouyu holds 50%of the equity of the company” is inconsistent with the actual situation.
Third, the performance margin payment disclosed by Announcement 54 is inconsistent with the actual situation. Haiyin signed the “Cooperation Contract” on June 11, 2019, and Haiyin paid a 20 million yuan performance deposit to Jinzhu Company on June 6, 2019, that is, the time to pay the performance deposit “Signing date. However, the 54th announcement disclosed that “After the contract was signed, the company intends to provide Professor Xu Mantai and his research team with a performance deposit of RMB 10 million in accordance with the contract”, which is inconsistent with the actual situation.
Fourth, the category of intending industrialized operations disclosed by Announcement 54 was inaccurate. Haiyin, Xu Mantai and Jinzhu Company intending to carry out industrialized operations “Jinzhu polysaccharide injection” is an animal preparation prepared by Nanyao for raw materials. It belongs to the vaccine, and there are significant differences in biological safety and ecological toxicity. In the “Cooperation Contracts” signed by all parties, the relevant expressions are called “injection liquid”. In the announcement of the 54th Announcement, Haiyin called “Jinzhu polysaccharide” as “vaccine”, and at the context, “Based on Professor Xu Moutai and his research team’s prevention of ‘African swine fever’ to achieve certain research results”, ” “The company intends to cooperate with the research team, invest in the field of natural drugs, support the prevention and control of” African swine fever ‘”and” provide 10,000 yuan as a performance deposit to prepare for the production of the “African swine fever’ prevention and control” There are inaccurate situations.
Fifth is the lack of relevant basis for preventing the effective efficiency of today’s beaded sugar injection disclosed by Announcement 54. According to Haiyin’s proposal, the parties of the “Cooperation Contract” referred to the news reports of overseas media on oral vaccines made by Spanish researchers using 13 wild boars, and combined with the current pearly polysaccharide injection filed by the competent department in the pig farm in the Swine Plague area of u200bu200bHainan Africa. The staged results of the recovery test, without obtaining the relevant experimental results of the effective efficiency prevention of African swine fever in Africa or official certification materials that have not been obtained. When the main content of the agreement “, a positive expression is adopted, which clearly uses the” preventive prevention of African swine fever not less than 92%”as a focus on the contract, but it is not disclosed at the same time. It is not included in the aforementioned situation in the “Risk Tips” announced by No. 54, and there are inaccurate and incomplete situations.
Six is u200bu200bthe lack of relevant basis for future performance forecast and capital operation disclosed by Announcement on the 54th. Haiyin Co., Ltd. has not carried out a sufficient and effective argument and due diligence, and does not conduct the rationality and realization of related matters to study and analyze and judge the basic data provided by Xu Mantai’s teamAfter a brief calculation, when the 54th announcement was excerpted “the main content of the cooperation agreement”, it was clearly stated that “recruiting operating teams by Party A” and “(now Zhu) 2019-2021 operating income of 500 million, 5 billion, and 5 billion, and 10 billion, net profit of 200 million, 1 billion, 200 billion “as the performance prediction indicators for the operating team and all shareholders of Haiyin shares, and also listed the” GMP production base of 1 billion yuan in the GMP production base of today’s annual output of 1 billion yuan of today’s pearl polysaccharides shooting fluid. Construction “” Application for Planning and Construction ‘Hainan South Medicine Deep Processing Industrial Park’ “and other information, which lists” before June 30, 2020, strive to be 30% of the acquisition of Party C (now the company) 30% before December 31, 2019 ” “Equity” and paid 700 million yuan of acquisitions in the form of “adding stocks” or “non -public offering of ordinary stocks”, and separately listed that “Party C (now Zhu Company) should be in accordance with the science and technology version or GEM board or GEM. There is an inaccurate situation of the information about the regulatory governance company of the listing and strive to launch the independent listing work as soon as possible.
Seventh, the important terms of the “Cooperation Contract” were not disclosed in accordance with regulations. Article 12 of the “Cooperation Contract” signed by Haiyin’s stock price and Xu Mantai stipulates: “Party B (Xu Mantai) and Party C (now Zhu) guarantee: all statements and guarantees, and the copy provided by the provided copy The pieces are real. Before signing this contract, Party A (Haiyin Co., Ltd.) did not verify its authenticity. Party B and Party C did not provide information for Party A for verification; Signing this contract. ” This clause shows that the parties’ patent rights, the prevention of the prevention of the today’s pearl polysaccharides, and the premise and foundation of Haiyin shares in Haiyin shares such as Jinzhu Company’s future performance have great uncertainty. This situation will have a great impact on investors’ decisions, which is an important clause.